Here, we disrupted the p70 S6 kinase (p70 s6k ) gene in murine embryonic stem cells to determine the role of this kinase in cell growth, protein synthesis, and rapamycin sensitivity. p70 s6k؊͞؊ cells proliferated at a slower rate than parental cells, suggesting that p70 s6k has a positive inf luence on cell proliferation but is not essential. In addition, rapamycin inhibited proliferation of p70 s6k؊͞؊ cells, indicating that other events inhibited by the drug, independent of p70 s6k , also are important for both cell proliferation and the action of rapamycin. In p70 s6k؊͞؊ cells, which exhibited no ribosomal S6 phosphorylation, translation of mRNA encoding ribosomal proteins was not increased by serum nor specifically inhibited by rapamycin. In contrast, rapamycin inhibited phosphorylation of initiation factor 4E-binding protein 1 (4E-BP1), general mRNA translation, and overall protein synthesis in p70 s6k؊͞؊ cells, indicating that these events proceed independently of p70 s6k activity. This study localizes the function of p70 s6k to ribosomal biogenesis by regulating ribosomal protein synthesis at the level of mRNA translation.
, is a unique kinase in higher eukaryotes and one whose function is believed to regulate protein synthesis (1) . This kinase originally was identified in a mammalian cellular fraction to phosphorylate ribosomal S6 protein in vitro (2) (3) (4) . p90 rsk is another serine͞ threonine kinase that is also able to phosphorylate S6 in vitro. However, some extracellular stimuli such as insulin induce the activation of p70 s6k and S6 phosphorylation without the activation of p90 rsk (5, 6) . Moreover, the macrolide rapamycin inhibits both p70 s6k activity and S6 phosphorylation but not p90 rsk activity, suggesting that p70 s6k likely is responsible for in vivo S6 phosphorylation (7) (8) (9) (10) (11) . Ribosomal S6 protein, located in a position in the 40S subunit, is thought to be a major functional site involved in tRNA and mRNA binding (12) (13) (14) . The sites phosphorylated in vivo are clustered at the carboxyl terminus, and the phosphorylated region of S6 is thought to lie within the cleft where mRNA binds, a location compatible with a role in the regulation of translation (15) . Indeed, S6 phosphorylation correlates with rates of mRNA translation (16) . Taken together, p70 s6k is a good candidate kinase for regulation of mRNA translation through S6 phosphorylation.
Rapamycin binds to FKBP12 in cells and inhibits the p70 s6k activity through binding to a third molecule termed FRAP (or mTOR, RAFT) (17) . Indeed, addition of rapamycin to cell cultures inhibits protein synthesis and, more specifically, translation of mRNAs encoding ribosomal proteins (18, 19) , suggesting that p70 s6k and S6 are important in these events. However, rapamycin also inhibits a variety of other cell growth-related events, including the activity of cyclindependent kinases (20, 21) , phosphorylation of CREM (22) , and phosphorylation of 4E-BP1 (23, 24) . In particular, 4E-BP1 (also termed PHAS1) is another regulatory molecule for mRNA translation. The drug induces accumulation of the dephosphorylated species of 4E-BP1 that binds to a translation initiation factor eIF-4E and suppresses translation initiation of cap-dependent mRNAs. Thus, the effects of rapamycin on mRNA translation and protein synthesis may be exerted through its inhibition of 4E-BP1 phosphorylation. To this end, we disrupted the p70 s6k gene in murine embryonic stem (ES) cells to define the function of p70 s6k in protein synthesis and cell growth, and also to define the role of the kinase in rapamycin-sensitive events.
MATERIALS AND METHODS

Targeted Disruption of the p70
s6k Gene in Mouse Embryonic Stem Cells. A portion (14 kb) of the p70 s6k gene was cloned from the 129SV mouse genomic library in the lambda FIXII vector (Stratagene) using full-length, 1.5-kb rat p70 s6k cDNA. The neo selection cassette was inserted in the opposite orientation at BamHI and ApaI sites, to disrupt an exon encoding a part of the catalytic domain (corresponding amino acids 207-237 in the p70 s6k protein). The downstream coding region is designed to be frame-shifted. PGKtk cassette (25) was then cloned at the 3Ј SpeI site. The resulting targeting vector featured 5 kb of homologous sequence on the long arm and 1.2 kb on the short arm. The R1 ES cell line was cultured in DMEM (GIBCO) supplemented with 15% fetal calf serum (FCS) and leukemia inhibitory factor (1,000 units͞ml, GIBCO) and transfected with the targeting vector as described (26) . Colonies were picked after 12 days in a selection medium containing 0.5 mg͞ml G418 (GIBCO) and 2 M gancyclovir (Syntex, Palo Alto, CA) (26) . Homologous recombination of the gene was screened by PCR and confirmed by Southern blotting. For isolating cells homozygous for the targeted allele, a heterozygous clone was grown in 6 mg͞ml G418 (27) . Resistant colonies were picked after 10 days in the highconcentration selection medium.
Southern Blotting. Genomic DNA was extracted from cultured cells, digested with PstI and EcoRI, and separated in 1% agarose gels. After denaturation and neutralization of the gel, DNA was transferred to nylon membranes and hybridized with a specific probe.
Western Blotting. Cells (5 ϫ 10 6 ) were washed with PBS and lysed at 4°C with 25 mM Tris⅐HCl, pH 7.4͞50 mM NaCl͞0.5% sodium deoxycholate͞2% Nonidet P-40 (NP40)͞0.2% SDS͞1 M phenylmethylsulfonyl fluoride (PMSF)͞50 g/ml aprotinin͞50 M leupeptin. Lysates were resolved by SDS͞8% (for p70͞85 s6k and p90 rsk ) or 15% (for 4E-BP1) polyacrylamide gels and transferred to nitrocellulose filters. After blocking of the filters with a solution containing 1% BSA, the filters were incubated with either a rabbit polyclonal antibody raised against the common carboxyl-terminal sequence (NSG-PYKKQAFPMISKRPEHLRMNL) of the p70 s6k and p85 s6k isoforms (C18, Santa Cruz Biotechnology), a rabbit polyclonal antibody raised against a 44-aa peptide representing residues 682-724 of p90 rsk (QLVKGAMAATYSALNSSKPTPQLK-PIESSILAQRRVRKLPSTTL) (anti-mouse rsk kinase, rsk-III, Upstate Biotechnology, Lake Placid, NY), or a rabbit polyclonal antibody raised against a recombinant His-tagged rat PHAS1 (4E-BP1), kindly provided by R. T. Abraham (Mayo Clinic, Rochester, MN) (28) . Specific reactive proteins were detected by an enhanced chemiluminescence (ECL) method, employing a donkey anti-rabbit Ig antibody linked to horseradish peroxidase (Amersham).
Kinase Activity. The specific activities of p70͞85 s6k were determined by [ 32 P] incorporation into S6 peptide in the immune complex as described previously (29) . Briefly, cells (5 ϫ 10 6 ) were washed with PBS and lysed at 4°C in 500 l of lysis buffer (10 mM potassium phosphate͞1 mM EDTA͞5 mM EGTA͞10 mM MgCl 2 ͞50 mM ␤-glycerophosphate͞1 mM Na 3 VO 4 ͞2 mM DTT͞40 g/ml PMSF͞0.1% NP40). The extract was incubated for 30 min at 4°C with the C18 antibody. The immune complex was absorbed to Protein G-coupled beads (Zymed) for 30 min and washed twice with the lysis buffer and once with kinase buffer (20 mM Tris⅐HCl, pH 7.5͞10 mM MgCl 2 ͞1 g/ml IP-20͞0.1 mg/ml BSA͞0.4 mM DTT). After the final wash, the immune complexes were suspended in 50 l of the kinase buffer containing 100 M unlabeled ATP, 200 Ci͞ml [␥- The reaction was allowed to proceed for 15 min at 30°C and terminated by the addition of 20 l of 250 mM EDTA and boiling for 5 min. After a brief centrifugation, the supernatant (25 l) was applied to phosphocellulose paper and radioactivity was determined by using a liquid scintillation counter.
S6 Phosphorylation in Vivo. Cells were incubated with 500 Ci͞ml of [ 32 P]orthophosphate (ICN) in phosphate-free medium for 3 hr in the presence or absence of rapamycin. Cells were lysed in a hypotonic buffer, and ribosomes were enriched by ultra centrifugation using a sucrose cushion as described previously (6, 30) . Ribosomal proteins then were separated on SDS͞10% polyacrylamide gels, and phosphorylated S6 (Ϸ32 kDa) was visualized by using the PhosphorImager and IMAGE QUANT analysis (Molecular Dynamics).
Polysomal Association. Polysomal mRNAs were separated from nonpolysomal mRNAs by sucrose gradient gels as described previously (19) . Briefly, cells (2 ϫ 10 7 ) were washed once with PBS, they were suspended for 10 min at 0°C in 1 ml of a buffer containing 10 mM NaCl, 10 mM Tris⅐HCl (pH 7.4), 15 mM MgCl 2 , 1.2% Triton X-100, 1.2% deoxycholate, and a ribonuclease inhibitor, RNasin 200 units͞ml (Promega). Nuclei were pelleted by centrifugation for 2.5 min at 10,000 ϫ g. The postnuclear supernatant (300 l) was layered over 11 ml of a 0.5-1.5 M sucrose gradient with a 1-ml cushion of 1.5 M sucrose. The sucrose solutions contained 2 mM Tris⅐HCl (pH 7.4), 25 mM NaCl, 5 mM MgCl 2 , and 100 g of heparin per ml. The gradients were centrifuged at 105,000 ϫ g for 3 hr at 4°C by using a Beckman SW28 rotor. Twelve fractions of 1 ml each were collected and RNA was extracted. RNA from each fraction then was applied to nitrocellulose membranes by using a slot blot apparatus. Membranes were hybridized with 32 Plabeled probes of human eEF-1␣ cDNA, hamster eEF-2 cDNA, human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA, and human ␤-actin cDNA (ref. 19 ; ref. 29 and references therein). Radioactivity of slot blots was scanned by using the PhosphorImager, and the relative counts in each fraction were determined by IMAGE QUANT analysis.
RESULTS
Targeted Disruption of the p70 s6k Gene. We generated mouse ES cells lacking p70 s6k expression by using homologous recombination (Fig. 1A) . Mutation of both p70 s6k alleles (p70 s6kϪ͞Ϫ ) was established from p70 s6kϩ͞Ϫ ES cells by selection in high doses of G418 (Fig. 1B) . p70 s6k protein was absent in p70 s6kϪ͞Ϫ ES cells (Fig. 1C) . As a control, comparable protein levels of p90 rsk in all of the samples are shown (Fig. 1C) . It should be noted that p70 s6k has a p85 s6k isoform that has 23 additional amino acids at its amino terminus (31) (32) (33) . The p70 s6k and p85 s6k isoforms are produced by alternative splicing of the first exons (31) . As is predicted by the fact that we disrupted the common exons of p70 s6k and p85 s6k encoding the catalytic domain (Fig. 1 A) , the p85 s6k isoform also was absent in p70 s6kϪ͞Ϫ ES cells (Fig. 1C) . We confirmed that there was no activity of p70͞85 s6k detected in the p70 s6kϪ͞Ϫ ES cells by using antibodies raised against the common carboxyl-terminal sequence (Fig. 1D) .
Proliferation of p70 s6k؊͞؊ Cells. p70 s6k is activated by various mitogenic stimuli, including epidermal growth factor, platelet-derived growth factor, insulin, and interleukin 2, and the activity remains high throughout the G 1 phase of the cell cycle (34, 35) . Kinase activation is thought to be essential for G 1 ͞S transition because microinjection of specific antibodies against p70 s6k abolishes the entry of the cells into the cell cycle (36) . Contrary to this previous observation, p70 s6kϪ͞Ϫ cells proliferated well (Fig. 2) , indicating that p70 s6k is not essential for G 1 ͞S transition. However, p70 s6kϪ͞Ϫ cells proliferated slower than parental cells (Fig. 2) , whereas p70 s6kϩ͞Ϫ cells demonstrated a similar growth rate as parental cells (data not shown). These data were reproducible over five independent experiments, and the slower-growing phenotype of p70 s6kϪ͞Ϫ cells was observed even when p70 s6kϪ͞Ϫ cells were replated in 2-to 5-fold higher densities than parental cells (data not shown). Cell cycle analysis demonstrated that 33.5 Ϯ 2.9% of the p70 s6kϩ͞ϩ cells are within the G 0 ͞G 1 stage with 2 N content of DNA, whereas 53.1 Ϯ 2.3% of p70 s6kϪ͞Ϫ cells are in G 0 ͞G 1 (mean Ϯ SD from three independent experiments using cells harvested 1 and 2 days after passage). These results indicate that p70 s6k activity has a positive influence on cell proliferation, especially on G 1 progression. Of interest, rapamycin inhibited cell proliferation of p70 s6kϪ͞Ϫ cells to a similar extent as parental cells, indicating that other events inhibited by the drug but independent of p70 s6k are also important for both cell proliferation and the action of rapamycin. Rapamycin is known to inhibit the activity of cyclin-dependent kinases (Cdks) through inhibition of elimination of p27 kip1 under certain conditions (20, 21) . Here, Cdk2 activity was not inhibited by a 3-hr treatment with rapamycin and was inhibited by approximately 30% after 24-hr treatment with rapamycin in both p70 s6kϩ͞ϩ and p70 s6kϪ͞Ϫ cells. These data suggest that Cdk2 activity is not a primary target of either rapamycin or p70 s6k , at least in embryonic stem cells.
In Vivo Phosphorylation of S6 and 4E-BP1. Ribosomal S6 protein is the best candidate for the in vivo substrate of p70 s6k . The cells were metabolically labeled with [ 32 P]orthophosphate in the presence or absence of rapamycin, and radiolabeled proteins in partially purified ribosomes were separated on SDS͞polyacrylamide gels (Fig. 3A) . In contrast to p70 s6kϩ͞ϩ cells or p70 s6kϩ͞Ϫ cells, which exhibited rapamycin-sensitive S6 phosphorylation, p70 s6kϪ͞Ϫ cells did not show any detectable S6 phosphorylation in vivo. The data establish that p70 s6k is the in vivo kinase for S6 phosphorylation.
The phosphorylation status of 4E-BP1 also is altered by rapamycin (38, 39) . The drug induces accumulation of the dephosphorylated species of 4E-BP1, as well as p70 s6k and S6. The in vivo phosphorylation status of 4E-BP1 was examined by its mobility in SDS͞polyacrylamide gels as described previously (23, 24, 28) . In contrast to S6, phosphorylation of 4E-BP1 was detected in p70 s6kϪ͞Ϫ cells to the same extent as in parental cells (Fig. 3B) . Furthermore, rapamycin induced the accumulation of a dephosphorylated form of 4E-BP1 in p70 s6kϪ͞Ϫ cells. These data indicate that 4E-BP1 phosphorylation is independent of p70 s6k activity. This is consistent with recent publications demonstrating that 4E-BP1 is a direct substrate of FRAP (28) or that 4E-BP1 phosphorylation is controlled by a parallel signaling pathway that bifurcates immediately upstream of p70 s6k (37) . Translation of mRNA Encoding Ribosomal Proteins. We and others previously reported that rapamycin selectively inhibits translation of mRNAs that encode ribosomal proteins and elongation factors (18, 19) . This set of mRNAs has a specific structure at the 5Ј terminus (termed 5ЈTOP mRNA for mRNAs with an oligopyrimidine tract at their transcriptional start). The transcription initiates at cytidine and is followed by at least a 6-pyrimidine stretch. This is usually followed by GC-rich regions in the 5Ј untranslated region, which potentially make loop-stem structures. More recently, it has been demonstrated that the activity of p70 s6k correlates with the translational status of 5ЈTOP mRNAs by using dominantnegative or rapamycin-resistant forms of p70 s6k (38) . We examined the status of polysomal association of elongation factor 1␣ (EF-1␣) mRNA, as a representative of the 5ЈTOP group of mRNAs, and of GAPDH mRNA as a representative of non-5ЈTOP mRNAs (Fig. 4) . Addition of serum after a 16-hr period of starvation increased the polysomal-associated fractions (fractions 2-6) of EF-1␣ mRNA in p70 s6kϩ͞ϩ cells, but not p70 s6kϪ͞Ϫ cells (Fig. 4A) , indicating that p70 s6k is responsible for the up-regulation of 5ЈTOP mRNA translation by mitogens. In contrast, addition of serum did not change the polysomal association of GAPDH mRNA in either p70 s6kϩ͞ϩ or p70 s6kϪ͞Ϫ cells (data not shown). It should be noted that and EcoRI, and separated in 1% agarose gel. After denature and neutralization of the gel, DNA was transferred to nylon membrane and hybridized with the 1.0-kb probe indicated in A. (C) Western blotting. Cells were treated with either vehicle (0.1% ethanol, Control) or rapamycin (10 ng͞ml, RAP) for 30 min. Proteins were extracted from cells, separated on SDS͞8% polyacrylamide gels, and transferred to nitrocellulose membranes. Immunoblotting was performed by using the ECL method. Antibodies used here were: for p70 s6k and p85 s6k , a rabbit polyclonal antibody raised against the common carboxylterminal sequence (C18); for p90 rsk , a rabbit polyclonal antibody raised against the carboxyl terminus of the kinase. (D) Kinase activity. Cells were prepared as described above. The specific activities of p70 s6k and p85 s6k were measured by using the C18 antibody and S6 peptide as a substrate. s6k ͞S6 might partially up-regulate 5ЈTOP mRNA in p70 s6kϪ͞Ϫ cells. This possibility includes the decrease in a repressor protein that binds specifically to 5ЈTOP mRNA.
The effects of rapamycin then were investigated in the p70 s6kϪ͞Ϫ cells (Fig. 4B) . In p70 s6kϩ͞ϩ cells, rapamycin profoundly reduced the polysomal association of EF-1␣ mRNA as we previously reported in other cell types (19) . Rapamycin also reduced the polysomal association of GAPDH mRNA, but to a much lower extent when compared with EF-1␣ mRNA (Fig. 4B Right) . This lower degree of inhibition in non-5ЈTOP mRNA association may be explained by the general inhibition of translational initiation through the inhibition of eIF-4E activity. Essentially identical results were obtained in p70 s6kϩ͞Ϫ cells (data not shown). In contrast, the specific effects of rapamycin on 5ЈTOP mRNA were eliminated in p70 s6kϪ͞Ϫ cells. Rapamycin inhibited polysomal association of both EF-1␣ mRNA and GAPDH mRNA to the same extent as it did for GAPDH mRNA in p70 s6kϩ͞ϩ cells. These findings were reproduced for another set of 5ЈTOP mRNA (EF-2 mRNA) and non-5ЈTOP mRNA (␤-actin mRNA) (data not shown). These results indicate that rapamycin exerts its particular inhibitory effects on 5ЈTOP mRNA translation through p70 Treatment of the cells with rapamycin for 3 hr inhibited protein synthesis by 34.2 Ϯ 6.3% and 26.1 Ϯ 3.7% (mean Ϯ SD, from six independent experiments) in p70 s6kϩ͞ϩ cells and p70 s6kϪ͞Ϫ cells, respectively. These data indicate that inhibition of overall protein synthesis by rapamycin is independent of p70 s6k activity for the most part. In addition, serum-induced, rapamycin-resistant p90 rsk activation similarly was observed in both p70 s6kϩ͞ϩ cells and p70 s6kϪ͞Ϫ cells, indicating that the absence of p70 s6k does not have an obvious effect on early events in mitogenic signaling (data now shown).
DISCUSSION
Deletion of the p70 s6k gene was achieved in ES cells by homologous recombination to define the function of p70 s6k in mammalian cells. Targeted disruption of the p70 s6k gene eliminated phosphorylation of ribosomal S6 protein and abrogated translational regulation of mRNAs encoding ribosomal proteins by serum and rapamycin in these murine ES cells. These data demonstrate that the function of p70 s6k resides in S6 phosphorylation and also in regulation of ribosomal protein synthesis at the level of mRNA translation. Ribosomal proteins are needed in equimolar amounts in ribosomal biogenesis. In prokaryotes, genes for ribosomal proteins are interspersed in a few operons and the translation of these operons are autogenously regulated by one of their products (39) . The translation of an operon is down-regulated whenever one of its products (i.e., a ribosomal protein) is in FIG. 3 . In vivo phosphorylation of S6 and 4E-BP1. (A) S6 phosphorylation in vivo. Cells were incubated with [ 32 P]orthophosphate in phosphate-free medium in the presence or absence of rapamycin (10 ng͞ml) for 3 hr. Cells were lysed in hypotonic buffer, and ribosomes were enriched by ultra centrifugation using a sucrose cushion. Ribosomal proteins were then separated on SDS͞10% polyacrylamide gels, and phosphorylated S6 (Ϸ32 kDa) was visualized by using the PhosphorImager and IMAGE QUANT analysis (Molecular Dynamics). (B) In vivo phosphorylation status of 4E-BP1. Cells were treated with vehicle or rapamycin as described in Fig. 1C . Protein extracts were separated on SDS͞15% polyacrylamide gels and immunoblotted by using a rabbit polyclonal antibody raised against 4E-BP1. The band with the highest mobility (␣) corresponds to hypophosphorylated 4E-BP1, and the bands with lower mobility (␤, ␥) correspond to hyperphosphorylated 4E-BP1 (23, 24, 28) .
FIG. 4.
Polysomal association of EF-1␣ mRNA and GAPDH mRNA. (A) Effects of serum deprivation͞addition. Cells were incubated in medium containing 0.1% FCS for 16 hr (Ϫserum). FCS (15%) was added, and cells were incubated for another 3 hr (ϩserum). Polysomal mRNAs were separated from nonpolysomal mRNAs by sucrose gradient gels. mRNA in each fraction was slot-blotted and hybridized with a 32 P-labeled cDNA probe for human EF-1␣. Radioactivity of slot blots was scanned by using the PhosphorImager, and the relative counts in each fraction were determined by IMAGE QUANT analysis (shown as a percentage of the total counts in 12 fractions). Fractions 2-6 correspond to polysomal fractions determined by OD260 measurement (data not shown). (B) Effects of rapamycin. Cells were incubated in medium containing 0.1% FCS for 16 hr, then incubated in medium containing 15% FCS (Control) or 15% FCS plus rapamycin (10 ng͞ml, RAP) for an additional 3 hr. Polysomal association of EF-1␣ mRNA or GAPDH mRNA was measured as described above. The percent inhibition of polysomal-associated EF-1␣ mRNA or GAPDH mRNA by rapamycin also is shown (Right). We also demonstrated that rapamycin inhibited 4E-BP1 phosphorylation, translation of general mRNA, and overall protein synthesis, independent of p70 s6k activity. The hypophosphorylated species of 4E-BP1 bind tightly to eIF-4E (an N 7 -methylguanosine cap-binding subunit of the eIF-4F complex) and prevent eIF-4E from associating with eIF-4G (a scaffolding protein in the eIF-4F complex). The phosphorylation of 4E-BP1 is thought to release eIF-4E and facilitate translational initiation of capped mRNA. Thus, the inhibition of 4E-BP1 phosphorylation by rapamycin provides an explanation for the inhibition of overall mRNA translation and protein synthesis in p70 s6kϪ͞Ϫ cells. Our data distinguish the role of p70 s6k from that of 4E-BP1 in the rapamycin-sensitive and FRAP-regulated pathway (Fig. 5) . FRAP plays a pivotal role in the regulation of protein synthesis in cells by regulating the overall translation-initiation rate through 4E-BP1 and by regulating ribosomal biogenesis through p70 s6k . Several aspects of the role of p70 s6k remain to be clarified. For example, despite using several commercially available antibodies, we have not been able to analyze CREM phosphorylation to date. In terms of ribosomal biogenesis, rRNA also is required in the same equimolar amounts as ribosomal proteins. The same FRAP pathway or p70͞85 s6k by itself might regulate rRNA synthesis. Indeed, there is a report demonstrating that rapamycin at a high concentration (1 g͞ml) inhibits rRNA synthesis (42) . The establishment of p70 s6kϪ͞Ϫ cells now permits direct investigation of the role of p70͞85 ES cells also may delineate the differential roles of the two isoforms of the kinase.
